Mäneka Puligandla
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 5
- Hematology top 10%
-
- Renal cell carcinoma treatment 18
- Blood properties and coagulation 3
-
- Bladder and Urothelial Cancer Treatments 11
-
- Cancer Immunotherapy and Biomarkers 7
-
- Renal and related cancers 5
-
- Intracerebral and Subarachnoid Hemorrhage Research 4
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Donna NeubergJeffrey I. ZwickerErik J. UhlmannCharlene MantiaGriffin M. WeberRobert FlaumenhaftJack D. StopaBruce Furie
- Partner nations
- United StatesCanadaPuerto Rico
In The Last Decade
Mäneka Puligandla
41 papers receiving 757 citations
Peers
Comparison fields: 5 of 80
- Internal Medicine 176
- Hematology 89
- Pulmonary and Respiratory Medicine 256
- Genetics 75
- Cardiology and Cardiovascular Medicine 144
Countries citing papers authored by Mäneka Puligandla
This map shows the geographic impact of Mäneka Puligandla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mäneka Puligandla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mäneka Puligandla more than expected).
Fields of papers citing papers by Mäneka Puligandla
This network shows the impact of papers produced by Mäneka Puligandla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mäneka Puligandla. The network helps show where Mäneka Puligandla may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mäneka Puligandla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 26 | |
| 2 | 2020 | 10 | |
| 3 | 2020 | 17 | |
| 4 | 2020 | 16 | |
| 5 | 2019 | 11 | |
| 6 | 2019 | 7 | |
| 7 | 2019 | 12 | |
| 8 | 2019 | 1 | |
| 9 | 2019 | 128 | |
| 10 | 2019 | 7 | |
| 11 | 2018 | 1 | |
| 12 | 2018 | 84 | |
| 13 | 2018 | 17 | |
| 14 | 2017 | 24 | |
| 15 | 2017 | 6 | |
| 16 | 2017 | 1 | |
| 17 | 2017 | 46 | |
| 18 | 2017 | 37 | |
| 19 | 2017 | 90 | |
| 20 | From Path-Segment Tiles to Loops and Labyrinths | 2013 | 3 |
About Mäneka Puligandla
Mäneka Puligandla is a scholar working on Internal Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 42 papers that have together received 759 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (18 papers), Bladder and Urothelial Cancer Treatments (11 papers), Cancer Immunotherapy and Biomarkers (7 papers), Renal and related cancers (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Intracerebral and Subarachnoid Hemorrhage Research (4 papers), Cancer Genomics and Diagnostics (4 papers) and Blood properties and coagulation (3 papers). The work is most often cited by research in Internal Medicine (176 citations), Hematology (89 citations) and Pulmonary and Respiratory Medicine (256 citations). Mäneka Puligandla has collaborated with scholars based in United States, Canada and Puerto Rico. Frequent co-authors include Donna Neuberg, Jeffrey I. Zwicker, Erik J. Uhlmann, Charlene Mantia, Griffin M. Weber, Robert Flaumenhaft, Jack D. Stopa, Bruce Furie, Naomi B. Haas and Robert S. DiPaola. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.